Responsible use of scarce health care benefits

South African Medical Journal

Volumn 97, Issue 1, 2007, Pages 38-39

  Burns, Derrik G ^a  

^a Medscheme Health Risk Management ^*  (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ABDOMINAL AORTA ANEURYSM; BUDGET; CANCER MORTALITY; CANCER SCREENING; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH EDUCATION; LABORATORY TEST; MAMMOGRAPHY; PATHOLOGY; PATIENT CARE; PREVALENCE; PROSTATE CANCER; PUBLIC HEALTH; RESOURCE ALLOCATION; RESOURCE MANAGEMENT; RISK REDUCTION; SELF EXAMINATION; SOUTH AFRICA; UTERINE CERVIX CANCER;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INSURANCE BENEFITS; SOUTH AFRICA;

EID: 33846460788     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Barrett A, Roques T, Small M, Smith RD. How much will herceptin really cost? BMJ 2006; 333: 1118-1120.
2. Pretorius C. Utilisation of pathology procedures in the South African private pathology sector between 2003 and 2005. S Afr Med J 2007; 97: 51-57 (this issue).
3. Rothberg AD, McLeod H, Walters L, Veller M. Screening for abdominal aortic aneurysm - a pilot study in six medical schemes. S Afr Med J 2007, 97: 58-62 (this issue).
4. Stewart-Brown S, Fanner A. Screening could seriously damage your health. BMJ 1997, 314: 533-534.
5. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003; 326: 901.
6. Hoffman M, Cooper D, Carrara H, et al. Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol 2003; 32: 573-577.
7. Dent DM, Panieri E. Screening for breast cancer - finding a place between common sense and the evidence base. S Afr Med J 2004, 94: 354-355.
8. Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ 1998; 17: 307-312.
9. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancy. JAMA 2006; 296: 2336-2342.